New clue in dengue infection

Researchers uncover an unusual requirement for dengue entry into cells

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A key step in how dengue virus invades mammalian cells has been uncovered, solving an ongoing conundrum and presenting a potential new drug target for a disease that infects up to 100 million people each year.
Dengue virus envelope
linkurl:David Goodsell, The Scripps Research Institute;http://commons.wikimedia.org/wiki/File:Dengue_envelope_1k4r.png
For years, researchers have struggled to fuse dengue virus with cell surfaces or even artificial membranes in the lab, preventing them from modeling how the virus -- for which there are currently no vaccines or effective medications -- infects cells. "Although the fusion step is required for dengue virus infection, this process is not completely understood," said linkurl:Rosa Maria del Angel;http://www.infectomica.cinvestav.mx/ in an email, a dengue researcher at the National Polytechnic Institute of Mexico who was not involved in the research. Now, linkurl:Leonid Chernomordik;http://www.nichd.nih.gov/about/staff/bio.cfm?nih_id=0010161111 and colleagues at the National Institutes of Health have pinpointed the source of the problem: Dengue requires an extra step to trigger fusion and infection. They published linkurl:their findings;http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1001131 online last week in PLoS Pathogens. Most mosquito and tick-borne viruses, including dengue, enter a cell though endocytosis. Once inside, the viral membrane fuses with the endosomal membrane to create a pore from which the viral genetic material escapes into the cytosol (see image below). Normally, a low pH environment within an endosome is sufficient to trigger fusion and the release of genetic material. But not for dengue virus -- a linkurl:2008 study;http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592694/?tool=pubmed using live-cell imaging found that dengue virus fuses membranes only after the endosome has traveled deep into the cell, long after a sufficiently low pH has been reached.
Dengue virus infects a cell
NIH
"They deserve a lot of credit for being creative and paying attention to this difference, which nobody else had really done," said linkurl:Margaret Kielian,;https://sites.google.com/site/kielianlab/contact-me a virologist at the Albert Einstein College of Medicine in New York, who was not involved in the research. "They've explained a discrepancy in the field."To identify the missing factor causing the late fusion, Chernomordik's team tagged dengue membranes with fluorescent probes, then watched for fusion with cell membranes and artificial membranes under various conditions. After years of testing, the team finally found the answer -- fusion occurs only when membranes are negatively charged, a condition present only in late endosomes. "It took quite a while to get there," laughed Chernomordik, "but the answer proved to be quite nicer than we expected." "It is really nice data that fits well with our previous results," linkurl:Jolanda Smit;http://www.rug.nl/staff/jolanda.smit/index of the University of Groningen, author of the 2008 live-cell tracking paper, wrote in an email to The Scientist. The virus may have evolved the strategy to prevent premature release of its genetic material, said Chernomordik, timing the release until the endosome is deep within the cell, close to the replication machinery.The new information provides a target for future therapies to disrupt fusion as well as a needed recipe for fusion in the laboratory, added Chernomordik. Using negatively charged membranes, researchers can now model fusion in the laboratory and test new antivirals to see which of them disrupts fusion, possibly preventing dengue infection. "We now have an assay which is simple and straight-forward," said Chernomordik. "We're now in a position to screen different antivirals."Zaitseva, E. et al., "Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids," PLoS Pathogens, 6:e1001131- 2010.
**__Related stories:__***linkurl:A new path for HIV entry;http://www.the-scientist.com/blog/display/55670/
[30th April 2009] *linkurl:Structure hints at Ebola's cunning;http://www.the-scientist.com/blog/display/54827/
[9th July 2008] *linkurl:New clues to flavivirus replication;http://www.the-scientist.com/news/display/24211/
[1st August 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Megan Scudellari

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo